Table of Contents
1 Industry Outlook 9
1.1 Industry Overview 9
1.1.1 Global Driver for Pharmaceutical Demand 12
1.1.2 R&D Pipeline in Pharmaceutical Industry 12
1.1.3 Top Pharma Drugs by Sales (In $Million) 13
1.2 Industry Trends 14
2 Report Outline 16
2.1 Report Scope 16
2.2 Report Summary 16
2.3 Research Methodology 17
2.4 Report Assumptions 18
3 Market Snapshot 19
3.1 Market Definition - Infoholic Research 19
3.2 Benefits of Immunotherapy 19
3.3 Segmented Addressable Market (SAM) 19
3.4 Trends of the Immunotherapy Drugs Market 20
3.5 Related Markets 21
3.5.1 Human Insulin 21
3.5.2 Oncology Drugs 22
4 Market Outlook 24
4.1 List of Cancer Immunotherapy Drugs Approved (2016- April 2019) 24
4.2 Market segmentation 26
4.3 PEST Analysis 27
4.4 Porter 5 (Five) Forces 28
5 Market Characteristics 29
5.1 DRO - Global Immunotherapy Drugs Market Dynamics 29
5.1.1 Drivers 29
5.1.1.1 High preference of immunotherapy over traditional chemotherapy 29
5.1.1.2 Growing incidence of lifestyle and chronic diseases 30
5.1.2 Opportunities 31
5.1.2.1 Emergence of biosimilars 31
5.1.2.2 Increasing opportunities in the emerging market 31
5.1.3 Restraints 32
5.1.3.1 High immunotherapy treatment costs 32
5.1.3.2 Complex manufacturing process 32
5.2 DRO - Impact Analysis 32
5.3 Key Stakeholders 33
6 Drug Type: Market Size and Analysis 35
6.1 Overview 35
6.2 Monoclonal Antibodies (mAbs) 36
6.3 Vaccine 38
6.4 Non-specific Immunotherapy 39
6.5 Adaptive Cell Therapy 40
6.6 Others 41
7 Treatment Area: Market Size and Analysis 43
7.1 Overview 43
7.2 Cancer 45
7.3 Inflammatory and Autoimmune Diseases 46
7.4 Infectious Disease 47
7.5 Others 48
8 Regions: Market Size and Analysis 50
8.1 Overview 50
8.2 North America 51
8.3 Europe 53
8.4 Asia Pacific 55
8.5 Rest of the World 56
9 Competitive Landscape 58
9.1 Overview 58
10 Vendor Profiles 61
10.1 AbbVie' Inc. 61
10.1.1 Overview 61
10.1.2 Geographic Revenue 63
10.1.3 Business Focus 64
10.1.4 SWOT Analysis 65
10.1.5 Business Strategies 65
10.2 Amgen' Inc. 66
10.2.1 Overview 66
10.2.2 Geographic Revenue 68
10.2.3 Business Focus 69
10.2.4 SWOT Analysis 69
10.2.5 Business Strategies 70
10.3 F. Hoffmann-La Roche Ltd. 70
10.3.1 Overview 70
10.3.2 Business Units 72
10.3.3 Geographic Revenue 73
10.3.4 Business Focus 73
10.3.5 SWOT Analysis 74
10.3.6 Business Strategies 75
10.4 Bristol-Myers Squibb 75
10.4.1 Overview 75
10.4.2 Geographic Revenue 78
10.4.3 Business Focus 79
10.4.4 SWOT Analysis 79
10.4.5 Business Strategy 80
10.5 Johnson & Johnson 81
10.5.1 Overview 81
10.5.2 Business Units 84
10.5.3 Geographic Revenue 85
10.5.4 Business Focus 86
10.5.5 SWOT Analysis 87
10.5.6 Business Strategies 87
10.6 Merck & Co.' Inc. 88
10.6.1 Overview 88
10.6.2 Business Units 91
10.6.3 Geographic Revenue 92
10.6.4 Business Focus 93
10.6.5 SWOT Analysis 94
10.6.6 Business Strategies 94
11 Companies to Watch For 95
11.1 Novartis AG 95
11.1.1 Overview 95
11.2 GlaxoSmithKline plc 98
11.2.1 Overview 98
11.3 AstraZeneca PLC 100
11.3.1 Overview 100
11.4 Eli Lilly and Company Ltd 101
11.4.1 Overview 101
12 Annexure 103
12.1 Abbreviations 103